D.E. Shaw & Co’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.3M | Buy |
723,183
+312,507
| +76% | +$12.7M | 0.02% | 556 |
|
|
2025
Q1 | $21.1M | Buy |
410,676
+45,132
| +12% | +$2.32M | 0.02% | 657 |
|
|
2024
Q4 | $20.2M | Buy |
365,544
+183,449
| +101% | +$10.2M | 0.01% | 670 |
|
|
2024
Q3 | $5.99M | Sell |
182,095
-87,698
| -33% | -$2.88M | 0.01% | 1205 |
|
|
2024
Q2 | $7.33M | Buy |
269,793
+73,281
| +37% | +$1.99M | 0.01% | 1068 |
|
|
2024
Q1 | $7.14M | Buy |
196,512
+155,985
| +385% | +$5.67M | 0.01% | 1102 |
|
|
2023
Q4 | $821K | Buy |
+40,527
| New | +$821K | ﹤0.01% | 2166 |
|
|
2023
Q3 | – | Sell |
-23,451
| Closed | -$424K | – | 3261 |
|
|
2023
Q2 | $424K | Buy |
23,451
+5,884
| +33% | +$106K | ﹤0.01% | 2390 |
|
|
2023
Q1 | $221K | Buy |
+17,567
| New | +$221K | ﹤0.01% | 2775 |
|